Nonglycemic effects of dipeptidyl peptidase-4 inhibitors

The review considers the major nonglycemic effects of dipeptidyl peptidase-4 inhibitors commonly used in diabetological practice, by using as an example sitagliptin, the first and most investigated representative of this class.

Saved in:
Bibliographic Details
Main Authors: A S Ametov, L L Kamynina
Format: Artigo
Language:Russo
Published: "Consilium Medicum" Publishing house 2013-01-01
Series:Терапевтический архив
Subjects:
type 2 diabetes mellitus
dipeptidyl peptidase-4 inhibitors
sitagliptin
nonglycemic effects
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31226
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items